Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
60%
Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
3(60.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1
Completed1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (60.0%)
N/A2 (40.0%)

Trials by Status

unknown120%
withdrawn120%
completed120%
not_yet_recruiting120%
recruiting120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DEVICE
Total Trials
5